Navigation Links
Data Published in The Lancet Compare Dabigatran Etexilate to Dose-Adjusted Warfarin Across RE-LY® Trial Centers
Date:8/29/2010

RIDGEFIELD, Conn., Aug. 29 /PRNewswire/ -- Boehringer Ingelheim today announced results from a pre-specified, retrospective, un-blinded sub-analysis of the RE-LY® trial – the largest atrial fibrillation outcomes trial ever conducted(2) – were published in The Lancet.  The sub-analysis evaluated the primary outcomes of RE-LY® in relation to each center's average time in therapeutic range (cTTR) (INR 2.0-3.0) for patients taking warfarin.(1)

Study centers were placed into one of four groups based on cTTR (<57.1%, 57.1%-65.5%, 65.5%-72.6% and >72.6%).(1) Primary outcomes were assessed across the three treatment arms (dabigatran etexilate 110mg BID, dabigatran etexilate 150mg BID, warfarin)(1) and demonstrated:

  • There was no significant interaction between cTTR and stroke and systemic embolism for either dabigatran etexilate 110mg BID or dabigatran etexilate 150mg BID compared to warfarin (interaction p=0.89 and 0.20)(1)

  • There was no significant interaction between cTTR and major bleeding with dabigatran etexilate 110mg BID (interaction p=0.50); however, there was a significant interaction when comparing dabigatran etexilate 150mg BID to warfarin (interaction p=0.03), with lower rates at centers where INR control was low, and similar rates at centers where control was higher(1)

  • There was no significant interaction between cTTR and intracranial bleeding for either dabigatran etexilate 110mg BID or dabigatran etexilate 150mg BID compared to warfarin (interaction p=0.71 and 0.89)(1)

"Well-controlled warfarin is very effective for the prevention of stroke in patients with atrial fibrillation; however, we know in clinical practice there can be large variations in the level of control," said Dr. Michael Ezekowitz, professor & vice president, clinical research,
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Results of Pilot Study Published in Journal Music and Medicine Reveal The Listening Program Helps Children With Down Syndrome Improve Speech Skills
2. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
3. Newly Published Data Demonstrate ASP EVOTECH® ECR Provides Cleaning That is Superior to Manual Cleaning of Flexible Endoscopes
4. Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by Pain Practice
5. New Report Patient Monitoring Emerging Markets (BRIC - Brazil, Russia, India and China) 2010 - 2014 Published by MarketsandMarkets
6. Data Published in Proceedings of National Academy of Sciences Highlights Potential of Micromets BiTE Antibody Platform
7. Groundbreaking Study Published in Nature Biotechnology Demonstrates Sensitivity of Single Molecule Test for Detection of Prostate Cancer
8. ADMIRE-HF Clinical Trial Published in the Journal of the American College of Cardiology
9. London Genetics Conference Proceedings Published in Drug Discovery Today
10. Anti-Fibrotic Data from Amira Pharmaceuticals LPA1 Receptor Antagonist Program Published in the British Journal of Pharmacology
11. Pivotal Trial Results for Motavizumab Published in Current Issue of Pediatrics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sept. 30, 2014  Synapse Biomedical Inc. ( www.synapsebiomedical.com ) ... the post-approval study of its NeuRx DPS® System ... meet the FDA enrollment requirement was implanted over ... The NeuRx DPS®, which is the only medical ... patients, is a humanitarian device that obtained approval ...
(Date:9/30/2014)... Sept. 30, 2014  eHealth, electronic access of ... access of this information, has become a major ... that has not translated into user-friendly, effective products. ... - http://photos.prnewswire.com/prnh/20140929/149123 For ... years developing MWD® Health Manager iEHR, a multilingual ...
(Date:9/30/2014)... Sept. 30, 2014 It is evident from the ... is not performing upto expectations due to the lack of ... with the intake of omega-3 fatty acids. Among omega-3 ingredient ... fish oil, attributed to the large vegetarian population in ... polyunsaturated fatty acid (PUFAs) ingredients is in growth stage of ...
Breaking Medicine Technology:Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 2Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 3MWD Challenges the Big eHealth Players With New Software for Your Smartphone 2Omega-3 Polyunsaturated Fatty Acids (PUFAs) - An Indian Market Overview 2
... The 2009 Frost & Sullivan European Medical ... the radiology applications market is conferred on Viatronix ... the diagnostic imaging space. , (Logo: ... Viatronix has shown dedication to both developing and ...
... PAC, a leading global provider of advanced analytical instruments ... of the ANTEK MultiTek(TM) testing system for the fast, ... and halides. Industries include BioFuels, Chemicals, Food & Beverage, ... , "MultiTek(TM) is the only instrument on the ...
Cached Medicine Technology:Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 2Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 3Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 4New ANTEK MultiTek(TM) by PAC Provides Fast, All-in-One Testing for Sulfur, Nitrogen, Halides 2
(Date:9/30/2014)... California (PRWEB) September 30, 2014 ... organic compounds, which are mixed with animal feed to ... gain, and improve gut health and digestion. Amidst the ... eggs and meat across the globe, the need for ... aquaculture sectors is on the rise, thereby driving demand ...
(Date:9/30/2014)... of patients with bowel cancer for a genetic condition ... ovarian cancers, new research has found. , In a ... of Medicine and researchers from the University of Exeter,s ... screening programme for a genetic condition known as Lynch ... a caused by changes in genes which check the ...
(Date:9/30/2014)... research report published in the October 2014 issue of ... detection of cancer as easy as a simple blood test. ... not only detect some cancers earlier than ever before, but ... as well as identify those more likely to develop cancer ... cancer detection, so helping to save peoples, lives," said Diana ...
(Date:9/30/2014)... HealthDay Reporter , MONDAY, ... given broad-spectrum antibiotics before the age of 2 may ... childhood, new research suggests. Broad-spectrum antibiotics target a ... the study. "It is a reason to think ... are picking," said lead researcher Dr. Charles Bailey, attending ...
(Date:9/30/2014)... 2014 Visit Pam and Steve’s quiet ... you will find a loving couple facing the most ... , Steve was diagnosed with ALS – ... – just before the couple’s second wedding anniversary. ... new video, “Care, Support & ALS,” that’s ...
Breaking Medicine News(10 mins):Health News:Rising Consumption of Meat and Meat Products to Fuel Growth in the Global Feed Acidifiers Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Consumption of Meat and Meat Products to Fuel Growth in the Global Feed Acidifiers Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Genetic test would help 'cut bowel cancer spread' 2Health News:Genetic test would help 'cut bowel cancer spread' 3Health News:New blood test determines whether you have or are likely to get cancer 2Health News:Antibiotic Use Before Age 2 Might Raise Obesity Risk, Study Says 2Health News:Antibiotic Use Before Age 2 Might Raise Obesity Risk, Study Says 3Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2
... brain development, the brains first cells neuroepithelial stem cells ... evolves into the various cells of the fully formed brain. ... critical for these stem cells to divide correctly. Without it, ... offers insight into the first steps of brain development, and ...
... QMed, Inc. (Nasdaq:,QMED) today announced financial results for ... Revenue for the year decreased to,$5,246,789 from $8,136,305 a ... $(0.66) per share on a diluted basis, compared to ... basis the previous year.,Revenue for the three-month period ended ...
... hairdressers, barbers , , WEDNESDAY, March 26 (HealthDay News) -- ... had high concentrations of coloring ingredients appear to be ... new report contends. , The authors said the findings ... -- that hair dyes appear to increase the risk ...
... Emergency Medicine is hosting the 11th annual Society of ... Mesa, Calif. As part of the forum, UC Irvine ... variety of related areas ranging from the continued decline ... computerized alcohol-use counseling. , Emergency department ...
... Aging Specialist to Consult with Award-Winning Mind Fitness ... America Conference,Booth #1317) -- CogniFit, Ltd., the company ... software that will enhance human cognitive,performance and health, ... of,Gloria Cavanaugh, long-time president of the American Society ...
... protein, study says. , , WEDNESDAY, March 26 (HealthDay News) -- Keeping ... because it,s harder for women to replace muscle that,s lost naturally ... of 29 healthy women and men, aged 65 to 80, found ... mass -- a key difference in the way women,s and men,s ...
Cached Medicine News:Health News:Key factor in brain development revealed, offers insight into disorder 2Health News:Key factor in brain development revealed, offers insight into disorder 3Health News:QMed, Inc. Reports Year-End and Fourth Quarter Results 2Health News:QMed, Inc. Reports Year-End and Fourth Quarter Results 3Health News:QMed, Inc. Reports Year-End and Fourth Quarter Results 4Health News:QMed, Inc. Reports Year-End and Fourth Quarter Results 5Health News:QMed, Inc. Reports Year-End and Fourth Quarter Results 6Health News:QMed, Inc. Reports Year-End and Fourth Quarter Results 7Health News:Now-Banned Hair Dyes Linked to Bladder Cancer 2Health News:UC Irvine researchers present latest findings at emergency medicine forum 2Health News:CogniFit to Work With Gloria Cavanaugh, Former ASA President 2Health News:Older Women Have Harder Time Preserving Muscle Than Men 2
... this is the universal lithotripter for ... urinary and biliary treatment. The system ... with other applications including cystoscopy, ureteronoscopy, ... system comprises the height adjustable urologist' ...
... This therapeutic system ... the patient in mind. ... surgery and ongoing therapy, ... low-risk and effective therapy. ...
... Reach a new dimension! That of the ... unequalled performance and ease of use. Enjoy ... electroconductive shock wave technology coupled with the ... system. Manage the patient treatment, X-ray and ...
... The MINILITH SL1 developed by STORZ ... of extensive experience in the field of ... of the specific requirements to be met ... therapy, as has been outlined above. The ...
Medicine Products: